Showing results (41-50 of 460) with videos related to
Sort By:
Pageof 46
Best Practice & Research. Clinical Gastroenterology|July 3, 2025
Quality in endoscopy trainingJohn Anderson, Roland ValoriAllergy and Asthma Proceedings|May 17, 2024
Hereditary angioedema with normal C1 esterase inhibitor: Current paradigms and clinical dilemmasCristine Radojicic, John AndersonClinical and Translational Allergy|January 26, 2022
Reviewing clinical considerations and guideline recommendations of C1 inhibitor prophylaxis for hereditary angioedemaJohn Anderson, Njeri MainaFrontiers in Immunology|July 13, 2018
Engineering Approaches in Human Gamma Delta T Cells for Cancer ImmunotherapyJonathan Fisher, John AndersonDiabetes, Obesity & Metabolism|April 8, 2017
Consistent findings in glycaemic control, body weight and hypoglycaemia with iGlarLixi (insulin glargine/lixisenatide titratable fixed-ratio combination) vs insulin glargine across baseline HbA1c, BMI and diabetes duration categories in the LixiLan-L trialCarol Wysham, Riccardo C Bonadonna, Vanita R Aroda, et al.Diabetes Care|September 22, 2016
Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized TrialVanita R Aroda, Julio Rosenstock, Carol Wysham, et al.Lancet (London, England)|June 29, 2021
Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trialJulio Rosenstock, Carol Wysham, Juan P Frías, et al.Critical Reviews in Oncology/Hematology|August 30, 2008
Adapting treatment for prostate cancer according to risk of disease progressionJohn Anderson, Cora N SternbergSouthern Medical Journal|March 12, 2005
Cholesterol emboli-induced renal failure and gastric ulcer after thrombolytic therapyWassim A Hitti, John AndersonPostgraduate Medicine|November 10, 2015
The importance of postprandial glycemic control: optimizing add-on therapy to basal insulinCharles F Shaefer, John AndersonPageof 46